Lipid profile in AD patients with respect to e2 and e4 carriers and non-carriers.
| Groups | ε2(+) n=4 | ε2(-) n=34 | P-value | P-value* | ε4(+) n=11 | ε4(-) n=27 | P-value | P-value* |
|---|---|---|---|---|---|---|---|---|
| TC | 170±50 | 185.3±40.9 | 0.7 | 0.4 | 189.7±30.9 | 181.2±45.3 | 0.6 | 0.6 |
| TG | 147.2±28.9 | 162.9±119.9 | 0.5 | 0.8 | 125.7±33.0 | 175.8±131.2 | 0.4 | 0.2 |
| LDL | 98±39.7 | 104.5±32.4 | 0.9 | 0.8 | 111.0±22.3 | 100.9±36.0 | 0.6 | 0.99 |
| HDL | 47.3±16.4 | 43.4±11.9 | 0.8 | 0.4 | 46.5±11.1 | 42.8±12.8 | 0.6 | 0.7 |
↵* Values are adjusted to age and gender, only one patient showed e3(-) which is not enough to achieve sufficient statistical power. Thus, we only reported e2(±) and e4(±), the results are expressed as mean±standard deviation, mg/dL, AD - Alzheimer disease, TC - total cholesterol, TG - triglycerides, LDL - low density lipoprotein, HDL - high-density lipoprotein